Results 91 to 100 of about 4,313 (158)

Eosinophilic cystitis refractory to multiple treatments with good response to benralizumab: case report. [PDF]

Front Allergy
Ruiz de Galarreta Beristain M, Audicana Berasategui MT, Bernedo Belar N, Mena Ruiz C, Moreno Nieto V, Uriel Villate O.   +5 more
europepmc   +1 more source

Benralizumab as a steroid-sparing rescue therapy in ANCA-negative eosinophilic granulomatosis with polyangiitis: real-world experience from three cases and review of the literature. [PDF]

Rheumatol Int
Sebastian A, Kosałka-Węgiel J, Puchala M, Życińska K, Kolarz B, Bieniasz-Pawlik E, Korkosz M.   +6 more
europepmc   +1 more source

Asthma remission with benralizumab therapy in severe eosinophilic Indian asthmatics. [PDF]

Lung India
Venkitakrishnan R, Menon G, Cleetus M, Divya R, Vijay A, Somson HT, John S.   +6 more
europepmc   +1 more source

Comment on 'A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma'. [PDF]

Clin Exp Allergy
Ying S, Li Q.
europepmc   +1 more source

Benralizumab in severe eosinophilic asthma: a comprehensive systematic review and meta-analysis of randomized controlled trials evaluating lung function, asthma control, and safety outcomes. [PDF]

Syst Rev
Al Mutair A, Alabbasi Y, Alharbi HF, Alyami H, Al-Shammari HM, Al-Omari AA, Bomozah EA, Aljarameez F, Daniyal M.   +8 more
europepmc   +1 more source

Case Report: Benralizumab-induced remission in adolescent-onset ANCA-positive eosinophilic granulomatosis with polyangiitis. [PDF]

Front Immunol
Terzic M, Plavsic A, Djordjevic S, Todorovic M, Bosic M, Arandjelovic S.   +5 more
europepmc   +1 more source

Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain. [PDF]

J Clin Med
García-Moguel I, Agüero Calvo J, Betancor Pérez D, Carretero Gracia JÁ, Díaz-Campos RM, Fernández Martínez de Septien C, Gómez-Bastero Fernández A, Hernández Galván Y, Lloret-Queraltó JA, Lluch Tortajada I, Malanda NM, Martín-García C, Martínez Mesa Á, Martínez-Moragon E, Medina Gallardo JF, Padilla-Galo A, Pérez Chica G, Plasencia García I, Prieto Montaño P, Puchaes Manchón C, Romero Ribate D, Valverde-Monge M, Zamarro Parra MS, Sanchez-Trincado JL, Nuevo J, Luzon E, Velasco-Garrido JL.   +26 more
europepmc   +1 more source

Monoclonal Antibodies Directed Against IL-5 in the Treatment of Pediatric Asthma. [PDF]

Cells
Fainardi V, Carbone R, Buono EV, Menzella M, Caffarelli C.   +4 more
europepmc   +1 more source

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study. [PDF]

Front Immunol
Codirenzi M, Davanzo F, Iorio L, Fiorin E, Guarnieri G, Chieco Bianchi F, Achille A, Marchi MR, Vianello A, Doria A, Ramonda R, Padoan R.   +11 more
europepmc   +1 more source

Biological treatments for asthma and chronic obstructive pulmonary disease. [PDF]

BMJ Med
Tejwani V, Siddharthan T, Majumdar U, Hatipoğlu U, Hanania NA.   +4 more
europepmc   +1 more source